Activated ras and ret oncogenes induce over-expression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cells

Oncogene
M IvanD Wynford-Thomas

Abstract

Hepatocyte Growth Factor (HGF) receptor, encoded by the protooncogene c-met, is overexpressed in many human tumours, including those of thyroid epithelium. The absence in most cases of any primary structural abnormality of the met gene suggests that overexpression is secondary to mutation of other gene(s). To test this hypothesis we investigated the effect on met expression of two activated oncogenes known to play a major role in thyroid oncogenesis, ras and ret. To minimize the possibility of unknown co-operating events, we introduced these genes directly into normal human thyrocytes in primary culture using amphotropic retroviral vectors and assessed met expression as early as possible in the resulting epithelial colonies. Double immunofluorescence revealed expression of met protein, strictly localized to cells expressing the mutant ras and ret vectors, expression in background normal cells being barely detectable. In contrast, colonies induced to proliferate at a comparable rate by a vector expressing SV40 T showed no increase in met expression. To permit quantitation by Western blotting we also extended these findings to a thyroid cell line (R18) containing a zinc-inducible mutant ras gene. Induction of the oncogene led to ...Continue Reading

Citations

Dec 17, 2010·International Journal of Clinical Oncology·Kazuyuki NumakuraTomonori Habuchi
Jan 5, 2008·Cancer Metastasis Reviews·Alessandra GentilePaolo M Comoglio
Feb 27, 2010·Endocrine Pathology·Elias SozopoulosSofia Tseleni-Balafouta
Nov 30, 2011·Hormones & Cancer·Alessia LocatelliCarol A Lange
Jun 14, 2005·Trends in Molecular Medicine·Simona CorsoSilvia Giordano
Aug 3, 2000·Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie·H G Suarez
Jul 11, 2001·Endocrinology and Metabolism Clinics of North America·E Puxeddu, J A Fagin
Aug 30, 2003·Surgical Oncology·Dorry L SegevMartha A Zeiger
Mar 25, 2006·Nature Reviews. Cancer·Tetsuo KondoSylvia L Asa
Jul 25, 2006·Nature Reviews. Cancer·Carla Boccaccio, Paolo M Comoglio
May 31, 2008·Nature Reviews. Drug Discovery·Paolo M ComoglioLivio Trusolino
Oct 3, 2000·Thyroid : Official Journal of the American Thyroid Association·J D BergströmN E Heldin
Nov 6, 2007·Antioxidants & Redox Signaling·Nathalie Hill-KapturczakAnupam Agarwal
May 28, 2013·Thyroid : Official Journal of the American Thyroid Association·Frauke BentzienF Michael Yakes
Mar 20, 2009·Molecular Biology of the Cell·Bénédicte FoveauDavid Tulasne
Apr 8, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E KapiteijnJ W A Smit
Jun 29, 2011·Anti-cancer Drugs·Patrick Chi-pan Lau, Anthony Tak-cheung Chan
May 25, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Razelle KurzrockRavi Salgia
Feb 19, 2010·Folia Histochemica Et Cytobiologica·Ewa LukasiewiczMarcin Majka
Apr 14, 2010·Biomarkers in Medicine·Liliane Goetsch, Véronique Caussanel
Mar 21, 2006·Proceedings of the National Academy of Sciences of the United States of America·Annalisa PetrelliSilvia Giordano
Sep 6, 2001·Proceedings of the National Academy of Sciences of the United States of America·K A FurgeC P Webb
Jul 17, 1998·Clinical Endocrinology·H G Suárez
Nov 1, 2005·Expert Review of Molecular Diagnostics·Orla Sheils
Sep 28, 2010·Expert Opinion on Investigational Drugs·Giulia M StellaPaolo M Comoglio
Jun 4, 2014·Endocrinology and Metabolism Clinics of North America·Mimi I HuCamilo Jimenez
Dec 21, 2013·Critical Reviews in Oncology/hematology·F GelsominoM Tiseo
Nov 1, 2008·Cancer·Doo-Sik KongDo-Hyun Nam
Dec 23, 2015·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Hisato Kawakami, Isamu Okamoto
Jul 4, 2009·The Lancet Oncology·Michalis V KaramouzisAthanasios G Papavassiliou
Jul 4, 2007·Journal of Cellular Physiology·Silvia Benvenuti, Paolo M Comoglio
May 2, 2006·Human Pathology·Ana Sofia RochaManuel Sobrinho-Simões
Mar 20, 2013·International Journal of Endocrinology·Serena GiuntiLibero Santarpia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Annalisa PetrelliSilvia Giordano
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Lei YeRobert F Gagel
© 2021 Meta ULC. All rights reserved